Source: MedCity News

AbbVie: AbbVie, Roche leukemia drug successful in Phase III confirmatory study

The companies said Venclexta extended overall survival in untreated acute myeloid leukemia patients when combined with Bristol-Myers Squibb's Vidaza. A prior Phase III confirmatory trial, combining the drug with low-dose cytarabine, failed.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from AbbVie's latest SEC filings

Annual Revenue

Based on data from AbbVie's latest SEC filings


Richard A. Gonzalez's photo - Chairman & CEO of AbbVie

Chairman & CEO

Richard A. Gonzalez

CEO Approval Rating


AbbVie discovers, develops and markets both biopharmaceuticals and small molecule drugs.

AbbVie's headquarters is located...
Read more